ASSESSING PREDICTORS OF DIRECTLY ACTING ANTIVIRALS’ FAILURE AS A FURTHER STEP TOWARDS MORE EFFICIENT HCV ELIMINATION PROGRAMS: IL28B (IFNL4) GENE POLYMORPHISM HAS NO ROLE WHILE HIGHER ESTIMATED CREATININE CLEARANCE IS A FORGOTTEN FACTOR

Autor: Ahmed KAMAL, Cecil MATTA, Heba Akram MOHSIN, Abeer Shawki ELHADIDI, Ramy Mohamed GHAZY, Heba Hany OMAR, Mona TAHOUN, Nema Abdelhameed MOHAMED

Publikováno v: Arquivos de Gastroenterologia, Volume: 59, Issue: 2, Pages: 177-183, Published: 06 JUL 2022
Arquivos de Gastroenterologia v.59 n.2 2022
Arquivos de gastroenterologia
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia
instacron:IBEPEGE

Background: Sustained virologic response (SVR) rates after directly acting antivirals (DAAs) for hepatitis C virus (HCV) exceed 95%. This encouraged policymakers to put plans to achieve HCV elimination by 2030. The remaining percentage of non-SVR12 c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ff8d746af6127d4e8b9a5b0c8d0b591
https://doi.org/10.1590/s0004-2803.202202000-33